Rhenman & Partners Asset Management AB - ALLOGENE THERAPEUTICS INC ownership

ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 160 filers reported holding ALLOGENE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.17 and the average weighting 0.3%.

Quarter-by-quarter ownership
Rhenman & Partners Asset Management AB ownership history of ALLOGENE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$951,000
-36.2%
300,0000.0%0.10%
-34.4%
Q2 2023$1,491,0000.0%300,0000.0%0.16%
-4.3%
Q1 2023$1,491,000
-30.3%
300,000
-11.8%
0.16%
-26.5%
Q4 2022$2,138,600
-38.9%
340,0000.0%0.22%
-39.2%
Q3 2022$3,502,000
-12.2%
340,000
-2.9%
0.37%
-19.0%
Q2 2022$3,990,000350,0000.45%
Other shareholders
ALLOGENE THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Vida Ventures Advisors, LLC 1,798,163$46,213,00013.24%
Wildcat Capital Management, LLC 1,716,370$44,111,0005.71%
TPG Group Holdings (SBS) Advisors, Inc. 18,716,306$481,009,0004.77%
Copernicus Capital Management, LLC 15,000$386,0004.67%
Coastal Bridge Advisors, LLC 301,240$7,742,0001.79%
Lombard Odier Asset Management (Switzerland) SA 914,416$23,500,0001.46%
Casdin Capital, LLC 2,100,000$53,970,0001.34%
Pier Capital, LLC 450,182$11,570,0001.20%
Ghost Tree Capital, LLC 150,000$3,855,0001.13%
Sessa Capital IM, L.P. 750,000$19,275,0000.95%
View complete list of ALLOGENE THERAPEUTICS INC shareholders